Simone Passerini

652 total citations
16 papers, 396 citations indexed

About

Simone Passerini is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Simone Passerini has authored 16 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Simone Passerini's work include HIV Research and Treatment (4 papers), Infection Control in Healthcare (4 papers) and HIV/AIDS drug development and treatment (3 papers). Simone Passerini is often cited by papers focused on HIV Research and Treatment (4 papers), Infection Control in Healthcare (4 papers) and HIV/AIDS drug development and treatment (3 papers). Simone Passerini collaborates with scholars based in Italy, Switzerland and United States. Simone Passerini's co-authors include Stefania Piconi, Giuliano Rizzardini, Daria Trabattoni, Mario Clerici, S. Parisotto, Mara Biasin, Paola Meraviglia, Amedeo Capetti, Lauren Clack and Hugo Sax and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Simone Passerini

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Passerini Italy 10 174 111 102 90 67 16 396
Cindy Brothers United States 7 414 2.4× 295 2.7× 167 1.6× 96 1.1× 73 1.1× 8 723
Denise Sutherland‐Phillips United States 7 493 2.8× 374 3.4× 195 1.9× 100 1.1× 86 1.3× 13 827
Rukmini Balu United States 8 91 0.5× 58 0.5× 27 0.3× 95 1.1× 126 1.9× 9 466
J.L. Pellegrin France 12 208 1.2× 128 1.2× 123 1.2× 101 1.1× 46 0.7× 27 463
Debra Sierka United States 11 138 0.8× 26 0.2× 35 0.3× 90 1.0× 120 1.8× 23 504
Paul Wannamaker United States 9 705 4.1× 534 4.8× 275 2.7× 116 1.3× 88 1.3× 16 1.1k
Laurence Moachon France 10 305 1.8× 123 1.1× 142 1.4× 126 1.4× 43 0.6× 19 587
Simone Becker United States 11 203 1.2× 83 0.7× 19 0.2× 184 2.0× 51 0.8× 13 461
Claudia Martorell United States 14 467 2.7× 217 2.0× 155 1.5× 598 6.6× 75 1.1× 28 1.3k
Sven Philip Aries Germany 8 122 0.7× 105 0.9× 72 0.7× 86 1.0× 113 1.7× 12 347

Countries citing papers authored by Simone Passerini

Since Specialization
Citations

This map shows the geographic impact of Simone Passerini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Passerini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Passerini more than expected).

Fields of papers citing papers by Simone Passerini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Passerini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Passerini. The network helps show where Simone Passerini may publish in the future.

Co-authorship network of co-authors of Simone Passerini

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Passerini. A scholar is included among the top collaborators of Simone Passerini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Passerini. Simone Passerini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Squillace, Nicola, Elena Ricci, Barbara Menzaghi, et al.. (2020). The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile. SHILAP Revista de lepidopterología. 1 indexed citations
2.
Pagani, Gabriele, Nadia Zanchetta, Laura Galimberti, et al.. (2020). Imported dengue fever: a 16-years retrospective analysis in Milan (Italy) and a brief review of the European literature. 28(2). 243–252. 6 indexed citations
3.
Squillace, Nicola, Elena Ricci, Barbara Menzaghi, et al.. (2020). <p>The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile</p>. Drug Design Development and Therapy. Volume 14. 5515–5520. 23 indexed citations
4.
Giacomelli, Andrea, Gabriele Pagani, Anna Lisa Ridolfo, et al.. (2020). Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study. Journal of Medical Virology. 93(3). 1421–1427. 16 indexed citations
5.
6.
Bogdanović, Jasmina, et al.. (2019). Exploring healthcare providers’ mental models of the infection prevention “patient zone” - a concept mapping study. Antimicrobial Resistance and Infection Control. 8(1). 138–138. 3 indexed citations
7.
Clack, Lauren, Simone Passerini, Aline Wolfensberger, Hugo Sax, & Tanja Manser. (2018). Frequency and Nature of Infectious Risk Moments During Acute Care Based on the INFORM Structured Classification Taxonomy. Infection Control and Hospital Epidemiology. 39(3). 272–279. 9 indexed citations
8.
Wolfensberger, Aline, Lauren Clack, Stefan P. Kuster, et al.. (2018). Transfer of pathogens to and from patients, healthcare providers, and medical devices during care activity—a systematic review and meta-analysis. Infection Control and Hospital Epidemiology. 39(9). 1093–1107. 36 indexed citations
9.
Clack, Lauren, Simone Passerini, Tanja Manser, & Hugo Sax. (2018). Likelihood of Infectious Outcomes Following Infectious Risk Moments During Patient Care—An International Expert Consensus Study and Quantitative Risk Index. Infection Control and Hospital Epidemiology. 39(3). 280–289. 8 indexed citations
10.
Passerini, Matteo, Monica Schiavini, C. Magni, et al.. (2018). Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience. European Journal of Gastroenterology & Hepatology. 30(10). 1208–1215. 19 indexed citations
11.
Rimoldi, Sara Giordana, Cristina Pagani, Pietro Romano, et al.. (2016). Pasteurella spp in Knee Mega Prosthesis Infection: A Case Report. 1(1).
12.
Taramasso, Lucia, Giordano Madeddu, Elena Ricci, et al.. (2014). Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals. Biomedicine & Pharmacotherapy. 69. 233–236. 5 indexed citations
13.
Piconi, Stefania, S. Parisotto, Giuliano Rizzardini, et al.. (2012). Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals. AIDS. 27(3). 381–389. 44 indexed citations
14.
Piconi, Stefania, S. Parisotto, Giuliano Rizzardini, et al.. (2011). Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy–treated immunologic nonresponders. Blood. 118(12). 3263–3272. 142 indexed citations
15.
Melzi, Sara, Laura Carenzi, Maria Vittoria Cossu, et al.. (2010). Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems. SHILAP Revista de lepidopterología. 2010. 1–13. 20 indexed citations
16.
Piconi, Stefania, Daria Trabattoni, Veronica Rainone, et al.. (2010). Immunological Effects of Sublingual Immunotherapy: Clinical Efficacy Is Associated with Modulation of Programmed Cell Death Ligand 1, IL-10, and IgG4. The Journal of Immunology. 185(12). 7723–7730. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026